FreeLLMOpenAI adquire a startup de biotecnologia IA Orchestra Bio
OpenAI adiciona os agentes de IA da Orchestra Bio para impulsionar sua plataforma de ciências da vida Rosalind, expandindo serviços de biotecnologia.
Assista no YouTube · Assista ao Short
OpenAI announced on October 20, 2026 that it has acquired Orchestra Bio, a four‑year‑old AI biotech software startup.
Orchestra Bio, backed by Andreessen Horowitz, Atria and 8VC with roughly $20 million raised by 2025, builds AI agents that manage drug‑discovery operations such as finance tracking and clinical‑trial scheduling.
The acquisition will integrate Orchestra’s team and technology into OpenAI’s Rosalind model and the Rosalind Workbench tool, which help researchers plan experiments and analyze results.
OpenAI cites existing Rosalind customers including Moderna and Novo Nordisk, indicating a growing market for AI‑driven life‑science tools.
Terms of the deal were not disclosed, and the move reflects a broader trend of large AI labs expanding into industry‑specific software.
O que isso significa para você
For AI users, the deal signals more specialized tools that combine large models with workflow automation in biotech. Those seeking free or locally hosted models may see increased competition for resources as commercial AI labs deepen domain‑specific offerings.
Fontes
- OpenAI acquires startup Orchestra Bio to beef up its biotech business, TechCrunch, 20 Oct 2026
- OpenAI acquires Orchestra Bio, OpenAI (official), 20 Oct 2026
Escrito automaticamente a partir das fontes acima, depois verificado pelo nosso código: todo número e nome deve aparecer nelas, e nenhuma frase pode copiar uma fonte. Encontrou um erro? Reporte‑o.
Qual IA você pode usar grátis hoje?
Todo modelo de IA gratuito, classificado por votos humanos cegos, com a memória e velocidade que ele precisa na sua própria GPU.